Bristol-Myers Squibb
BMY
BMY
2,490 hedge funds and large institutions have $97.3B invested in Bristol-Myers Squibb in 2026 Q1 according to their latest regulatory filings, with 266 funds opening new positions, 1,044 increasing their positions, 860 reducing their positions, and 150 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 2,437 → 2,490 (+53)
4% less call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.54B
1.88% less ownership
Funds ownership: 80.62% → 78.73% (-1.9%)
Holders
2,490
Holding in Top 10
34
Calls
$1.48B
Puts
$1.54B
Top Buyers
| 1 | +$1.02B | |
| 2 | +$997M | |
| 3 | +$401M | |
| 4 |
SG Americas Securities
New York
|
+$366M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$345M |
Top Sellers
| 1 | -$732M | |
| 2 | -$595M | |
| 3 | -$485M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$452M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$417M |
